Clinical Trials

ProPharma Group is Supporting Better Clinical Outcomes Down Under

ProPharma

Lipid Nanoparticle Development

Lipid Technology for Delivery of Gene-Editing Therapies

Stephen Burgess, Ph.D.

Croda Pharma

Column: M&A

Why the Big Shifts in Gene Therapy Investments? It’s Late in the Game

Nigel Walker

Nice Insight

Gene Therapy Analytics

Overcoming Analytical Challenges for Gene Therapies

Jennifer Chadwick, Ph.D.

ProtaGene

Viral Vector Manufacturing

Optimizing Yields, Tech Transfer, and the Supply Chain for Viral Vector Manufacturing

Andrew Moreo; Lenore Giannunzio

Andelyn Biosciences

Gene Therapy Manufacturing

Leveraging Partnerships and a Unique History to Address Supply Chain and Capacity Challenges in Gene Therapy Manufacturing

Wade Macedone; Adam Lauber

Andelyn Biosciences

Cell and Gene Therapy

Quality and Regulatory Challenges Surrounding New Cell and Gene Therapy Products

Jennifer Cheung

WuXi Advanced Therapies

Gene Therapy

Beyond 2020: Looking into the Crystal Ball for Gene Therapy

Ratish Krishnan

MilliporeSigma

AAV Platform Technologies

Increasing Predictability with AAV Platform Technologies

Felix Hsu

WuXi Advanced Therapies